{"id":2716,"date":"2016-06-02T12:50:53","date_gmt":"2016-06-02T16:50:53","guid":{"rendered":"https:\/\/www.bu.edu\/amyloid\/?page_id=2716"},"modified":"2017-02-02T15:16:03","modified_gmt":"2017-02-02T20:16:03","slug":"2016-2","status":"publish","type":"page","link":"https:\/\/www.bu.edu\/amyloid\/research\/publications\/2016-2\/","title":{"rendered":"2016"},"content":{"rendered":"

Salinaro F, Meier-Ewert HK, Miller E, Shivda P, Sanchorawala V, Berk JL, Seldin DC, Ruberg FL.<\/strong> Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis. European Heart Journal – Cardiovascular Imaging<\/em>, 0, 1-8, 2016 Dec 12. \u00a0 \u00a0 \u00a0\u00a0 View in: PubMed<\/a><\/p>\n

Ruberg FL, Fontana M, Gillmore JD<\/strong>. Should histologic determination of Amyloid load determine management decisions in light-chain Amyloidosis? J Am Coll Cardiol. 68(22):2493-2494,\u00a02016 Dec 6. View in: PubMed<\/a><\/p>\n

Nolin AC, Mulhern RM, Panchenko MV, Pisarek-Horowitz A, Wang Z, Shirihai O, Borkan SC,<\/strong> Havasi A<\/b>. Proteinuria causes dysfunctional autophagy in the proximal tubule. <\/o:p>Am J Physiol Renal Physiol<\/span>. 311(6):F1271-F1279, 2016 Dec 1. View in: PubMed<\/a><\/p>\n

Prokaeva T<\/strong>, Spencer B, Sun F, O’Hara RM, Seldin DC, Connors LH, Sanchorawala V. <\/strong>Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio. 23(4):214-220, 2016 Dec. View in: PubMed<\/a><\/p>\n

Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, Dispenzieri A, Grogan M, Johnson G, Bokhari S, Maurer MS.<\/strong> Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis. 1(8):880-889, 2016 Nov 1.\u00a0 View in: PubMed<\/a><\/p>\n

Havasi A<\/b>, Stern L, Lo S, Sun F, Sanchorawala V<\/strong>. Validation of new renal staging system in AL amyloidosis treated with high dose melphalan and stem cell transplantation. <\/strong><\/o:p>Am J Hematol<\/span>. 91(10):E458-60, 2016 Oct. View in: PubMed.<\/a><\/p>\n

Havasi A, Lu W, Cohen HT, Beck LH Jr, Wang Z, Igwebuike C, Borkan SC.<\/strong> Blocking peptides & molecular mimicry as treatment for kidney disease. <\/strong><\/o:p>Am J Physiol Renal Physiol<\/span>. <\/span>DOI:<\/span> 10.1152\/ajprenal.00601.2015, <\/span>2016 Sep 21. View in: PubMed<\/a><\/p>\n

Menn-Josephy H, Lee CS, Nolin A, Christov M, Rybin DV, Weinberg JM, Henderson J, Bonegio R, Havasi A.<\/strong> Renal interstitial fibrosis: an imperfect predictor of kidney disease progression in some patient cohorts. Am J Nephrol<\/span>. 44(4):289-299, 2016 Sep 15. View in: PubMed<\/a><\/p>\n

Sanchorawala V,\u00a0Shelton AC, Lo S, Varga C, Sloan JM, Seldin DC. \u00a0<\/strong>Pomalidomide and dexamethasone in the treatment of AL amyloidosis: \u00a0results of a phase 1 and 2 trial. \u00a0Blood<\/em>,\u00a0128(8):1059-1062, 2016. \u00a0View in: PubMed<\/a><\/p>\n

Haq M, Pawar S, Berk JL, Miller EJ, Ruberg FL.<\/strong> Can 99m-Tc-Pyrophosphate aid in early detection of cardiac involvement in asymptomatic variant TTR Amyloidosis? JACC Cardiovasc Imaging. pii: S1936-878X(16)30443-0, 2016 Aug 20. View in: PubMed<\/a><\/p>\n

Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN.<\/strong> Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 133(24):2404-12.\u00a02016 Jun 14. View in: PubMed<\/a><\/p>\n

Lee SY, Brauneis D, Stern L, Sanchorawala V.<\/strong>\u00a0 Optimal dosing of high-dose melphalan prior to autologous hematopoietic stem cell transplantation in a patient with AL amyloidosis and a solitary kidney. \u00a0Hematol Oncol Stem Cell Ther,<\/em>\u00a09(2):86-8, 2016. \u00a0View in: <\/span>PubMed<\/a><\/p>\n

Havasi <\/b>A, Dong Z.<\/strong> Autophagy and tubular cell death in the kidney. <\/o:p>Semin Nephrol. <\/span>Review. 36(3):174-88, 2016 May. View in: PubMed<\/a><\/p>\n

Sanchorawala V, Gale RP<\/strong>. \u00a0David C Seldin, MD, PhD: scientist, clinician, teacher, gentleman, 1957-2015. \u00a0Bone Marrow Transplant,<\/em>\u00a051(3):323, 2016. \u00a0View in: <\/span>PubMed<\/a><\/p>\n

Connors LH, Sam F, Skinner M, Salinaro F, Sun F, Ruberg FL, Berk JL, and Seldin DC.<\/strong>\u00a0 Heart failure due to age-related cardiac amyloid disease associated with wild-type transthyretin:\u00a0 a prospective, observational cohort study.\u00a0 Circulation<\/em>, 133:282-290, 2016. \u00a0View in: <\/span>PubMed<\/a><\/p>\n

Bever KM, Masha LI, Sun F, Stern L, Havasi A, Berk JL, Sanchorawala V, Seldin DC, Sloan JM<\/strong>. Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis. Haematologica<\/em>, 101(1):86-90, 2016. \u00a0View in: PubMed<\/a><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Salinaro F, Meier-Ewert HK, Miller E, Shivda P, Sanchorawala V, Berk JL, Seldin DC, Ruberg FL. Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis. European Heart Journal – Cardiovascular Imaging, 0, 1-8, 2016 Dec 12. \u00a0 \u00a0 \u00a0\u00a0 View in: PubMed Ruberg FL, Fontana M, Gillmore JD. Should […]<\/p>\n","protected":false},"author":8316,"featured_media":0,"parent":88,"menu_order":3,"comment_status":"closed","ping_status":"open","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/2716"}],"collection":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/users\/8316"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/comments?post=2716"}],"version-history":[{"count":9,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/2716\/revisions"}],"predecessor-version":[{"id":3054,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/2716\/revisions\/3054"}],"up":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/88"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/media?parent=2716"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}